Condition: Chronic Hepatitis D Infection · Fibrosis, Liver · Hepatocellular Carcinoma · Sponsor: Yaşar Bayındır, MD
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
This description comes directly from the study's public registry record.
Yaşar Bayındır, MD · 00905323659909 · yasar.bayindir@guven.com.tr
Mustafa Kemal Çelen, MD · 00905336207022
Always discuss trial participation with your own doctor first.
| Guven Hospital | Ankara, Turkey (Türkiye) | Recruiting |
| Dicle University, Faculty of Medicine | Diyarbakır, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06248580